BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20825270)

  • 1. Clinical burden of venous thromboembolism.
    Ruppert A; Lees M; Steinle T
    Curr Med Res Opin; 2010 Oct; 26(10):2465-73. PubMed ID: 20825270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates.
    Mahan CE; Borrego ME; Woersching AL; Federici R; Downey R; Tiongson J; Bieniarz MC; Cavanaugh BJ; Spyropoulos AC
    Thromb Haemost; 2012 Aug; 108(2):291-302. PubMed ID: 22739656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of venous thromboembolism in hospitalized patients.
    Dobesh PP
    Pharmacotherapy; 2009 Aug; 29(8):943-53. PubMed ID: 19637948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term complications of medical patients with hospital-acquired venous thromboembolism.
    Fanikos J; Piazza G; Zayaruzny M; Goldhaber SZ
    Thromb Haemost; 2009 Oct; 102(4):688-93. PubMed ID: 19806254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated annual costs of prophylaxis and treatment of venous thromboembolic events associated with major orthopedic surgery in France.
    Tilleul P; LaFuma A; Colin X; Ozier Y
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):473-84. PubMed ID: 17000893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.
    Cohen AT; Agnelli G; Anderson FA; Arcelus JI; Bergqvist D; Brecht JG; Greer IA; Heit JA; Hutchinson JL; Kakkar AK; Mottier D; Oger E; Samama MM; Spannagl M;
    Thromb Haemost; 2007 Oct; 98(4):756-64. PubMed ID: 17938798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism: a chronic illness.
    Mason C
    J Cardiovasc Nurs; 2009; 24(6 Suppl):S4-7. PubMed ID: 19858962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-cause and disease-related health care costs associated with recurrent venous thromboembolism.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Hossou Y; Schein J; Kaatz S
    Thromb Haemost; 2013 Dec; 110(6):1288-97. PubMed ID: 24085327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboprophylaxis in orthopedic surgery: how long is long enough?
    Muntz J
    Am J Orthop (Belle Mead NJ); 2009 Aug; 38(8):394-401. PubMed ID: 19809604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.
    Grosse SD; Nelson RE; Nyarko KA; Richardson LC; Raskob GE
    Thromb Res; 2016 Jan; 137():3-10. PubMed ID: 26654719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic surgery is associated with a lower incidence of venous thromboembolism compared with open surgery.
    Nguyen NT; Hinojosa MW; Fayad C; Varela E; Konyalian V; Stamos MJ; Wilson SE
    Ann Surg; 2007 Dec; 246(6):1021-7. PubMed ID: 18043105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of venous thromboembolism occurrence in medical patients among the insured population.
    Spyropoulos AC; Hussein M; Lin J; Battleman D
    Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
    Streiff MB
    J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in patients hospitalized with nephrotic syndrome.
    Kayali F; Najjar R; Aswad F; Matta F; Stein PD
    Am J Med; 2008 Mar; 121(3):226-30. PubMed ID: 18328307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
    Isma N; Svensson PJ; Gottsäter A; Lindblad B
    Thromb Res; 2009 Dec; 124(6):663-6. PubMed ID: 19497611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Venous thromboembolism in the elderly].
    Méan M; Aujesky D
    Rev Med Suisse; 2009 Oct; 5(223):2142-4, 2146. PubMed ID: 19968026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
    Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.